NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
(Total Views: 330)
Posted On: 08/15/2019 4:08:25 PM
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Q2 2019 Financial Results, Provides Business Update
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced financial results for the second quarter ended June 30, 2019, provided a business update, and offered guidance for the remainder of the fiscal year and for FY 2020. In the update, the company reported 2019 second quarter highlights that include record consumables sales, strong growth in BaroFold and UST Services, and launch of a revolutionary CBD processing system. “Because of the poor water solubility of today’s oil-based CBD products, most ingested CBD is flushed from the body, leaving little of the product to provide its beneficial properties,” Pressure BioSciences President and CEO Richard T. Schumacher said in the news release. “After much diligence and analysis, we concluded that we have the expertise and experience to successfully address this critical issue. Consequently, we pulled significant hours away from many of our staff over the past few months and had them focus on the development of an instrument system – based on our patented UST platform – that would increase the water-solubility, and thus the absorption, of CBD Oil. We succeeded; the result of that success is the BaroShear K45 processing system.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced financial results for the second quarter ended June 30, 2019, provided a business update, and offered guidance for the remainder of the fiscal year and for FY 2020. In the update, the company reported 2019 second quarter highlights that include record consumables sales, strong growth in BaroFold and UST Services, and launch of a revolutionary CBD processing system. “Because of the poor water solubility of today’s oil-based CBD products, most ingested CBD is flushed from the body, leaving little of the product to provide its beneficial properties,” Pressure BioSciences President and CEO Richard T. Schumacher said in the news release. “After much diligence and analysis, we concluded that we have the expertise and experience to successfully address this critical issue. Consequently, we pulled significant hours away from many of our staff over the past few months and had them focus on the development of an instrument system – based on our patented UST platform – that would increase the water-solubility, and thus the absorption, of CBD Oil. We succeeded; the result of that success is the BaroShear K45 processing system.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼